General Actions (Not specific medical benefits for the user)
| Core Action | Mechanism |
| Provides Basal Coverage | Insulin Glargine forms microprecipitates upon injection, which dissolve slowly to release insulin over a long period, providing a sustained, relatively peakless concentration of insulin for up to 24 hours. |
| Controls Fasting Glucose | The consistent, steady action is essential for controlling the body's baseline glucose production and consumption, effectively lowering fasting and overnight blood sugar levels. |
| Reduces Hypoglycemia Risk | Compared to older intermediate-acting insulins, its peakless profile often results in a reduced risk of nocturnal hypoglycemia (low blood sugar overnight). |
| Convenient Dosing | The long duration of action allows for once-daily injection, simplifying the patient's injection schedule and improving compliance. |
⚠️ Important Safety Note:
Abasaglar KwikPen is a life-saving prescription medication. Insulin therapy requires careful management. The most serious risk is hypoglycemia (dangerously low blood sugar). Never reuse needles or share pens. Dosage and timing are critical and must be determined by a specialist. Please consult a qualified healthcare professional (Endocrinologist/Diabetologist) before starting, stopping, or changing any insulin regimen. They can provide accurate medical advice, training, and monitor treatment.
Warning! You must be logged in to submit a review.
Login
Customer questions & answers
Customer reviews
0 out of 5